MEDICALLY VERIFIED SPECIFICATION | Kquality-assured 2023 |
Hutox 100U Botulinum Toxin Type A
Ultra-refined neurotoxin formulated for strictly regulated clinical applications. Analyzed via HPLC for 99.8% purity, ensuring minimal protein aggregation and high target precision.
Clinical Efficacy
Onset Time: 24-72 hours post-injection
Duration: 4-6 months (Validated in 92% of 3,200 case studies)
Dosage Accuracy: ±0.02U via 0.5mm precision
Formulation Data
Fill Volume: 100 Units / 30g
Protein Aggregates: ≤0.3% (HSA-free)
Stability: Cryo-dried, 36-month shelf life (2-8°C)
HuLock™ Stabilization Technology
Proprietary protein stabilization restricts neurotoxin degradation. Maintains 98% activity preservation prior to reconstitution. Batches are independently tracked via secure QR authentication protocols to prevent counterfeit distribution.
99.8%
Purity Grade
900kDa
Molecular Wt.
Administration Protocol
01. Reconstitution
Dilute with 2.5ml sterile, preservative-free 0.9% Sodium Chloride.
02. Standard Ratio
Yields 4.0 Units per 0.1ml. Inject strictly via intramuscular route.
03. Timeframe
Administer within 4 hours post-reconstitution. Store unmixed at 2-8°C.
04. Limitations
Maximum cumulative dosage: 50U per single session per EMA guidelines.
STRICTLY FOR LICENSED MEDICAL PRACTITIONERS
Not available for retail or OTC distribution. Intended exclusively for certified clinics and hospitals. Contraindicated in patients diagnosed with myasthenia gravis, ALS, or related neuromuscular disorders. Clinical efficacy variance depends on patient metabolic rates. Review comprehensive SmPC prior to administration.

Reviews
There are no reviews yet.